As a leading regeneration expert in the area of dentistry and with over 750 employees worldwide, Geistlich wants to make the ecological, social and economic impact of its work measurable and improve it. To this end, the family-owned company has undergone the Swiss Triple Impact (STI) program initiated by B Lab Switzerland. This program enables Swiss companies to measure their contribution to the Sustainable Development Goals (SDGs) and thus improve their sustainability performance.
The global market leader in regenerative dentistry is proud to have successfully completed the program and to now be a member of the STI Directory. In it, Geistlich has committed to providing high-quality training in regenerative dentistry free of charge to more than 500 dentists worldwide every year starting in 2025.
Ralf Halbach, CEO of Geistlich Pharma AG, says: "Sharing our expertise and know-how in the field of dental regeneration is in our DNA. By joining the Swiss Triple Impact as a Directory Leader, we aim to improve the health of patients worldwide, especially in developing countries."
In addition to this, Geistlich wants to increase the proportion of women in its management team and is aiming for gender parity by 2030. Likewise, the Swiss production site for Geistlich Biomaterials in Wolhusen is to become climate-neutral by 2030.
The specific Swiss Triple Impact goals can be viewed here: Geistlich Pharma AG (swisstripleimpact.ch)